Trial Profile
An open-label observational safety study during administration of Topamac [topiramate], for the prophylaxis of migraine
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Oct 2009
Price :
$35
*
At a glance
- Drugs Topiramate (Primary)
- Indications Migraine
- Focus Therapeutic Use
- Sponsors Janssen-Cilag
- 20 Mar 2008 Status changed from in progress to completed based on information from ClinicalTrials.gov.
- 30 Jul 2007 Status changed from initiated to in progress.
- 29 Jun 2007 Status change from recruiting to initiated.